Does the company have any items and products that extract the vines? Xinbang Pharmaceutical: The company currently has no related business_ Oriental Fortune Net Post date May 16, 2022 — 20:09 Post Lock Read More Xinbang Pharmaceutical: The company currently does not have Qianjinteng alkali related business_Oriental Fortune Net Post date May 16, 2022 — 20:09 Post Lock Read More Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews Post date May 10, 2022 — 19:03 Post Lock Read More The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm Post date May 10, 2022 — 18:49 Post Lock Read More The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there? Post date May 9, 2022 — 12:28 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical: The company currently does not have Qianjinteng alkali related business_Oriental Fortune Net Post date May 16, 2022 — 20:09 Post Lock Read More Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews Post date May 10, 2022 — 19:03 Post Lock Read More The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm Post date May 10, 2022 — 18:49 Post Lock Read More The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there? Post date May 9, 2022 — 12:28 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Rumors of "false positives" once forced the stock price of Runda Medical to stop: regulatory intervention to investigate the differentiation of nucleic acid detection sector into new coronary pneumonia jqknews Post date May 10, 2022 — 19:03 Post Lock Read More The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm Post date May 10, 2022 — 18:49 Post Lock Read More The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there? Post date May 9, 2022 — 12:28 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The "false positive" rumors once forced the stock price of Runda to stop! Regulatory involvement in the investigation, the nucleic acid detection sector is differentiated – yqqlm Post date May 10, 2022 — 18:49 Post Lock Read More The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there? Post date May 9, 2022 — 12:28 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The son inherits the father's business! The son of the former chairman of Zhongqingbao takes office as the "post-90s" and "heirs" of the A-share market. Who else is there? Post date May 9, 2022 — 12:28 Post Lock Read More R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
R&D expenses of A-share pharmaceutical companies increased by 306 sales expenses of over 100 million Stock Channel Hexun.com Post date May 9, 2022 — 04:42 Post Lock Read More A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A-share pharmaceutical companies’ expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion in advertising expenses, and BeiGene invests the most in R&D_Shenzhen Hotline Post date May 8, 2022 — 21:55 Post Lock Read More A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
A-share pharmaceutical company’s expenses magnifying glass during the period: Shanghai Pharmaceuticals spends 6.2 billion advertising expenses, BeiGene invests the most in R&D Post date May 8, 2022 — 20:56 Post Lock Read More Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Guangyuyuan——2022·Traditional Chinese Medicine set sail ❤️ Website link Shenzhen Guangyuyuan Museum opened on April 26, and the 3,600-square-meter complex was operated in a high-profile manner. Build a high-end brand of traditional Chinese medicine?? Annual Report Focus 1… Snowball Post date May 3, 2022 — 18:04 Post Lock Read More Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Medical beauty concept stocks have been sought after by 600 million main funds in the past three days_Oriental Fortune Net Post date April 26, 2022 — 18:07 Post Lock Read More Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical: Currently there is no plan to repurchase shares, and it has not received any plan to increase its holdings from major shareholders jqknews Post date April 25, 2022 — 19:47 Post Lock Read More [News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[News] Bank of China Blue Chip Select Announces the Top 10 Heavy Holding Stocks in the First Quarterly Report CFi.CN Post date April 22, 2022 — 12:20 Post Lock Read More The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
The medical conference is about to be held, the demand for medical services is rigid, and it is expected to usher in restoration after the epidemic. Which targets are expected to benefit? _Shenzhen Hotline Post date April 16, 2022 — 05:03 Post Lock Read More [Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
[Express] SINBON Pharma Announces Annual Report CFi.CN Post date April 15, 2022 — 04:25 Post Lock Read More Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): Resolution of the Supervisory Board CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): Special Explanation on the Use of Annual Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): Renewed the 2022 Audit Institution CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): Independent directors' prior approval opinions on matters related to the seventh meeting of the eighth board of directors- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): 2021 Annual Work Report of the Supervisory Committee CFi.CN Post date April 15, 2022 — 04:20 Post Lock Read More Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More Want to see more data? Registered subscribers can see all the data. Register Now!
Xinbang Pharmaceutical (002390): Annual Attestation Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 15, 2022 — 04:20 Post Lock Read More
Caishen.CoCaishen.Co